Latest update:
Monday, April 22, 2024 - 13:34
“Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for March 2024 the Company recorded a decrease in sales of 24% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 32% decrease in export sales, mainly due to destabilizing market dynamics on the main export destinations.
From the beginning of 2024, the Company recorded a decrease in sales of 11%, incl. 1% decrease of domestic sales and 16% decrease in export sales.
Use of cookies
We would like to use cookies to better understand your use of this website. This helps us improve your future experience when visiting our website. If you continue your visit on our website, we shall assume that you agree with the cookies used. Detailed information on the use of cookies on this website and how to manage or withdraw your consent at any time, can be found in our